References
- PrasadBEversRGuptaAInterindividual variability in hepatic organic anion-transporting polypeptides and P-glycoprotein (ABCB1) protein expression: quantification by liquid chromatography tandem mass spectroscopy and influence of genotype, age, and sexDrug Metab Dispos2014421788824122874
- PrasadBLaiYLinYUnadkatJDInterindividual variability in the hepatic expression of the human breast cancer resistance protein (BCRP/ABCG2): effect of age, sex, and genotypeJ Pharm Sci2013102378779323280364
- KathawalaRJGuptaPAshbyCJChenZSThe modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decadeDrug Resist Updat20151811725554624
- ShenFChuSABaileyBQuantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cellsJ Pharmacol Exp Ther200832419510217947497
- SzakacsGPatersonJKLudwigJABooth-GentheCGottesmanMMTargeting multidrug resistance in cancerNat Rev Drug Discov20065321923416518375
- JiaPWuSLiFBreast cancer resistance protein-mediated topotecan resistance in ovarian cancer cellsInt J Gynecol Cancer20051561042104816343180
- LouisaMSoediroTMSuyatnaFDIn vitro modulation of P-glycoprotein, MRP-1 and BCRP expression by mangiferin in doxorubicin-treated MCF-7 cellsAsian Pac J Cancer Prev20141541639164224641381
- LiuJLiJLiuNIn vitro studies of phospholipid-modified PAMAM-siMDR1 complexes for the reversal of multidrug resistance in human breast cancer cellsInt J Pharm20175301–229129928619457
- MorrowCSPeklak-ScottCBishwokarmaBKuteTESmithermanPKTownsendAJMultidrug resistance protein 1 (MRP1, ABCC1) mediates resistance to mitoxantrone via glutathione-dependent drug effluxMol Pharmacol20066941499150516434618
- LiJLiuJGuoNZhangXReversal of multidrug resistance in breast cancer MCF-7/ADR cells by h-R3-siMDR1-PAMAM complexesInt J Pharm2016511143644527444552
- HilovskaLJendzelovskyRJendzelovskaZKovalJFedorockoPDownregulation of BCRP and anti-apoptotic proteins by proadifen (SKF-525A) is responsible for the enhanced mitoxantrone accumulation and toxicity in mitoxantrone-resistant human promyelocytic leukemia cellsInt J Oncol20154741572158426252082
- RenZGZhaoQWeiYXEstablishment of erlotinib-resistant HepG2 cell line and its resistant mechanismsChin J Pharmacol Toxicol2012266823828
- GreijerAEde JongMCSchefferGLShvartsAvan DiestPJvan der WallEHypoxia-induced acidification causes mitoxantrone resistance not mediated by drug transporters in human breast cancer cellsCell Oncol2005271434915750206
- YeCGWuWKYeungJHIndomethacin and SC236 enhance the cytotoxicity of doxorubicin in human hepatocellular carcinoma cells via inhibiting P-glycoprotein and MRP1 expressionCancer Lett20113042909621377266
- YanFWangXMLiuZCPanCYuanSBMaQMJNK1, JNK2, and JNK3 are involved in P-glycoprotein-mediated multidrug resistance of hepatocellular carcinoma cellsHepatobiliary Pancreat Dis Int20109328729520525557
- VolkELRohdeKRheeMMethotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug effluxCancer Res200060133514352110910063
- YaoXSunYWukaiMAOver-expression of mdr1/P-gp is associated with methotrexate resistance in patients with rheumatoid arthritisXi Bao Yu Fen Zi Mian Yi Xue Za Zhi2017336815819 Chinese28615105
- ZhaiBJWuFShaoZYHuKZhaoCLWangZBEstablishment of human hepatocellular carcinoma multidrug-resistance cell line (HepG2/Adm) and study apoptosis induced by low-frequency pulse ultrasound exposure]Chin J Hepatol20041229598 Chinese
- GarrawayLAChabnerBMDR1 inhibition: less resistance or less relevance?Eur J Cancer200238182337234012460776
- LeonardGDFojoTBatesSEThe role of ABC transporters in clinical practiceOncologist20038541142414530494
- YassineHBorgesCRSchaabMRMass spectrometric immunoassay and MRM as targeted MS-based quantitative approaches in biomarker development: potential applications to cardiovascular disease and diabetesProteomics Clin Appl201377–852854023696124
- GroerCBruckSLaiYLC-MS/MS-based quantification of clinically relevant intestinal uptake and efflux transporter proteinsJ Pharm Biomed Anal20138525326123973632
- YangTChenFXuFWangFXuQChenYA liquid chromatography-tandem mass spectrometry-based targeted proteomics assay for monitoring P-glycoprotein levels in human breast tissueClin Chim Acta201443628328924972002
- LiNPalandraJNemirovskiyOVLaiYLC-MS/MS mediated absolute quantification and comparison of bile salt export pump and breast cancer resistance protein in livers and hepatocytes across speciesAnal Chem20098162251225919209887
- ZhangYLiNBrownPWOzerJSLaiYLiquid chromatography/tandem mass spectrometry based targeted proteomics quantification of P-glycoprotein in various biological samplesRapid Commun Mass Spectrom201125121715172421598331
- YuSJiangJZhaoSWeiDJieDIWangBExpression and significance of ATP-binding cassette proteins in hepatocellular carcinomaChin J Clin Oncol201037190193
- Gomez-MartinezAGarcia-MoralesPCarratoAPost-transcriptional regulation of P-glycoprotein expression in cancer cell linesMol Cancer Res20075664165317579122
- TaipalensuuJTavelinSLazorovaLSvenssonACArturssonPExploring the quantitative relationship between the level of MDR1 transcript, protein and function using digoxin as a marker of MDR1-dependent drug efflux activityEur J Pharm Sci2004211697514706813
- MohammadISHeWYinLUnderstanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDRBiomed Pharmacother201810033534829453043